People of color are less likely than others to receive timely treatment for medical issues. This is reflected in Covid-19 vaccination numbers, in cancer treatment, and in clinical trial participation. Experts discuss ways to increase participation, especially in clinical trials that might ultimately raise trust in medicine.


  • Dr. Lance Okeke, Asst. Prof. of Medicine and Infectious Diseases, Duke Univ
  • Dana Dornsife, founder and CEO, Lazarex Cancer Foundation
  • Mike McDaniel, participant in ACTIV-2 clinical trial.  

Additional Links:

Join the discussion

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.